🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Multi-center, prospective non-interventional study to collect data on the e...
Status
Terminated
Location
Banner Health MD Anderson Cancer Center
Start Date
2023-09-15
Trial ID
NCT06026332
Treatments Being Tested
The primary purpose of this trial is to evaluate the safety \& tolerability...
Status
Recruiting
Location
Mayo Clinic - Scottsdale Arizona
Start Date
2025-06-12
Trial ID
NCT06668493
Treatments Being Tested
In this phase 4 trial (000439), subjects with NMIBC CIS (± high-grade Ta/T1...
Status
Withdrawn
Location
Ferring Investigational Site
Start Date
2024-06-17
Trial ID
NCT06390111
Treatments Being Tested
This phase II trial tests the effect of intravesical nadofaragene firadenov...
Status
Not Yet Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-09-01
Trial ID
NCT07332351
This study will evaluate intrapleural administration of Adenovirus-Delivere...
Status
Completed
Location
University of California, Los Angeles (UCLA) - Medical Center
Start Date
2019-01-21
Trial ID
NCT03710876
Treatments Being Tested
A phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Ob...
Status
Recruiting
Location
University of South Alabama (USA) Health System - USACM
Start Date
2024-10-01
Trial ID
NCT06510374
Treatments Being Tested
The purpose of this study is to compare the effectiveness of different FDA-...
Status
Recruiting
Location
Johns Hopkins University (Data Collection Only)
Start Date
2025-04-11
Trial ID
NCT06929286
Treatments Being Tested
To evaluate the safety and efficacy of FE 999326 in Japanese subjects with ...
Status
Active Not Recruiting
Location
Ferring Investigational Site
Start Date
2022-12-21
Trial ID
NCT05704244
Treatments Being Tested
The pivotal phase 3 trial (rAd-IFN-CS 003) evaluating the efficacy of nadof...
Status
Recruiting
Location
Center for Neurosciences
Start Date
2024-10-01
Trial ID
NCT06545955
Treatments Being Tested